Among patients enrolled in the trial , 245 ( 16.3 % ) were elderly , allocated to BMS ( n = 132 ) or EES ( n = 113 ) , while the remaining 1253 ( 83.7 % ) were non-elderly , allocated to BMS ( n = 615 ) or EES ( n = 638 ) .